Fleury company profile
Company profile
Fleury has 32,000 employees and is headquartered in São Paulo, Brazil.
Diagnostic Medicine, one of the two segments of Fleury S.A. and its subsidiaries, centers on diagnostic imaging and clinical analysis, alongside fertility services and infusions, all provided in Brazil. The second segment, Integrated Medicine, groups medical services that include laboratory support, health management, orthopedics, ophthalmology, toxicological tests and assistance medicine. The group also runs a health platform, an immunobiological drug infusion center and ophthalmology service centers.
In the fiscal year ended 31 December 2025, Fleury reported revenue of BRL 8.3 billion, up 7.9% from the previous year, and net income of BRL 612.8 million. The company employs 32,000 people and is headquartered in São Paulo, where it was founded in 1926.
Company facts
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- Brazil
- Headquarters
- Avenida Morumbi, 04703-003, São Paulo
- Employees
- 32,000
- Chief executive
- Jeane Tsutsui
- Founded
- 1926
- Fiscal year
- January - December
- Listing
- FLRY3 · B3
- Indices
- Ibovespa
- Currency
- BRL
- ISIN
- BRFLRYACNOR5
- Website
- ri.fleury.com.br
Fleury and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| FleuryFLRY3 | Brazil | $1.97B | 32,000 | 16.0% | 15.0 |
| Diagnosticos da AmericaDASA3 | Brazil | $686.17M | 26,255 | 10.9% | — |
| DiagnostykaDIA | Poland | $1.27B | 8,645 | 14.9% | 20.2 |
| DiaSorinDIA | Italy | $4.21B | 3,212 | 22.3% | 28.6 |
| Sonic HealthcareSHL | Australia | $7.13B | 47,000 | 9.3% | 17.6 |
| WuXi XDC Cayman2268 | Hong Kong SAR China | $9.64B | 3,628 | 28.1% | 46.6 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
